FindTrial
Sign In

Comparison of ED95 of rocuronium between sex in children.

Comparison of ED95 of rocuronium between sex in children. - Comparison of ED95 of rocuronium between sex in children.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042628
Enrollment
28
Registered
2020-12-05
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of ED95 of rocuronium between sex in children.

Interventions

None listed

Sponsors

Nihon University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children undergoing general anesthesia at the age of 6-12 2. American society of anesthesiology physical status (ASA) 1 or 2 3. Patients with written parental consent for participation in this study

Exclusion criteria

Exclusion criteria: 1. Neuromuscular diseases 2. Rapid sequence induction 3. Taking any drug known to interact with neuromuscular blocking agents 4. Severe hepatic diseases 5. Dialysis patients 6. Predicted difficult airways

Design outcomes

Primary

MeasureTime frame
ED95 of rocuronium—

Secondary

MeasureTime frame
Recovery time from rocuronium administration to 25%, 90%, 100% of control—

Countries

Japan

Contacts

Public ContactHanae Sato

Nihon University School of Medicine Department of Anesthesiology

nakamura.hanae@nihon-u.ac.jp+81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026